A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses
Clinical trial NCT07063342 · RECRUITING
Trial details
- NCT number
- NCT07063342
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2027-03-29
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.